Sofie Verbeke
Overview
Explore the profile of Sofie Verbeke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
244
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Raman L, Van der Linden M, De Vriendt C, Van den Broeck B, Muylle K, Deeren D, et al.
Haematologica
. 2020 Dec;
107(1):211-220.
PMID: 33299235
Shallow-depth sequencing of cell-free DNA, a cheap and standardized approach to obtain molecular information on tumors non-invasively, is insufficiently explored for lymphoma diagnosis and disease follow-up. This study collected 318...
22.
Sundahl N, Vandekerkhove G, Decaestecker K, Meireson A, De Visschere P, Fonteyne V, et al.
Eur Urol
. 2019 Jan;
75(5):707-711.
PMID: 30665814
Preclinical data indicate that radiotherapy works synergistically with pembrolizumab, but the effect and toxicity of this combination may depend on radiotherapy timing. We conducted a randomized phase 1 trial combining...
23.
Van Bockstal M, Baldewijns M, Colpaert C, Dano H, Floris G, Galant C, et al.
Histopathology
. 2018 Sep;
73(6):923-932.
PMID: 30168167
Aims: Robust prognostic markers for ductal carcinoma in situ (DCIS) of the breast require high reproducibility and thus low interobserver variability. The aim of this study was to compare interobserver...
24.
Van Haverbeke C, Ferdinande L, Verbeke S, Van Dorpe J, Creytens D
Pathology
. 2018 May;
50(4):475-478.
PMID: 29731141
No abstract available.
25.
Van Bockstal M, Camboni A, De Vlieghere E, De Ryck F, Candaele A, Geenen S, et al.
Histopathology
. 2018 Feb;
72(7):1228-1230.
PMID: 29393528
No abstract available.
26.
Buelens S, Poelaert F, Dhondt B, Fonteyne V, De Visschere P, Ost P, et al.
Urol Oncol
. 2018 Jan;
36(4):158.e13-158.e20.
PMID: 29336978
Objectives: No uniformity exists in the definition of metastatic burden in metastatic hormone-naive prostate cancer (mHNPC) across clinical trials making their comparison challenging. We explored definition agreement and prognostic significance...
27.
Sundahl N, De Wolf K, Rottey S, Decaestecker K, De Maeseneer D, Meireson A, et al.
J Transl Med
. 2017 Jul;
15(1):150.
PMID: 28662677
Background: Current first-line standard of therapy for metastatic urothelial carcinoma is platinum-based combination chemotherapy. Pembrolizumab in phase III has demonstrated a promising overall response rate of 21.1% in patients with...
28.
Van Bockstal M, Hoorens A, Van den Bosch F, Creytens D, Verbeke S, Van Dorpe J
Virchows Arch
. 2017 Feb;
470(4):465-468.
PMID: 28168330
No abstract available.
29.
Cogen A, Bries G, Verbeke S, Van Schil P
Eur J Cardiothorac Surg
. 2012 Dec;
43(3):e89-91.
PMID: 23220936
We report a case of CD20+ grey zone lymphoma (GZL) with Reed Sternberg cells as an unexpected pathological diagnosis of a destroyed right lower lobe after necrotizing pneumonia. These GZLs...
30.
Marechal E, Cras P, Parizel P, Creytens D, Verbeke S, Helsen G
Acta Neurol Belg
. 2012 Feb;
111(4):337-9.
PMID: 22368977
Following chronic daily headache, neoplastic meningitis was diagnosed in a non-smoking 44-year-old man. A bronchial adenocarcinoma was found to be the primary tumor. He was treated with erlotinib. Meningitis as...